Literature DB >> 2531771

Prolactin secretion and dehydroepiandrosterone sulphate plasma levels in women with benign breast disease.

E Parlati1, I Liberale, A Travaglini, P Morelli, E Menini, S Dell'Acqua.   

Abstract

The purpose of the present investigation was to verify possible positive correlations between prolactin secretion and dehydroepiandrosterone sulphate levels in plasma of women with benign breast disease. Prolactin secretion was evaluated in terms of basal levels, maximum peak, percent increase above baseline levels, total integrated area, response area after TRH stimulation. No correlation was found between the parameters of prolactin secretion and dehydroepiandrosterone sulphate levels.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2531771     DOI： 10.1007/BF03350757

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


  17 in total

1.  Raised serum prolactin levels associated with hirsutism and amenorrhoea.

Authors:  M Seppälä; E Hirvonen
Journal:  Br Med J       Date:  1975-10-18

2.  Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization.

Authors:  B I Posner; P A Kelly; R P Shiu; H G Friesen
Journal:  Endocrinology       Date:  1974-08       Impact factor: 4.736

3.  Disordered nocturnal prolactin regulation in women with breast cancer.

Authors:  W B Malarkey; L L Schroeder; V C Stevens; A G James; R R Lanese
Journal:  Cancer Res       Date:  1977-12       Impact factor: 12.701

4.  Bromocriptine for treatment of benign breast disease. A double-blind clinical trial versus placebo.

Authors:  E Parlati; U Polinari; G Salvi; C Giorlandino; I Liberale; G Fiorella; S Dell'Acqua
Journal:  Acta Obstet Gynecol Scand       Date:  1987       Impact factor: 3.636

5.  Serum prolactin levels in patients with fibrocystic breast disease.

Authors:  F Peters; W Schuth; B Scheurich; M Breckwoldt
Journal:  Obstet Gynecol       Date:  1984-09       Impact factor: 7.661

6.  Prolactin has a direct effect on adrenal androgen secretion.

Authors:  K Higuchi; H Nawata; T Maki; M Higashizima; K Kato; H Ibayashi
Journal:  J Clin Endocrinol Metab       Date:  1984-10       Impact factor: 5.958

7.  Prolactin modulation of dehydroepiandrosterone sulfate secretion.

Authors:  R A Lobo; O A Kletzky; E M Kaptein; U Goebelsmann
Journal:  Am J Obstet Gynecol       Date:  1980-11-15       Impact factor: 8.661

8.  Prediction of response to endocrine therapy in pronounced cyclical mastalgia using dynamic tests of prolactin release.

Authors:  S Kumar; R E Mansel; L E Hughes; C A Edwards; M F Scanlon
Journal:  Clin Endocrinol (Oxf)       Date:  1985-12       Impact factor: 3.478

9.  Plasma androgens in women with hyperprolactinaemic amenorrhoea.

Authors:  F Bassi; G Giusti; L Borsi; S Cattaneo; P Giannotti; G Forti; M Pazzagli; C Vigiani; M Serio
Journal:  Clin Endocrinol (Oxf)       Date:  1977-01       Impact factor: 3.478

10.  Hormonal profile in benign breast disease. Endocrine status of cyclical mastalgia patients.

Authors:  E Parlati; A Travaglini; I Liberale; E Menini; S Dell'Acqua
Journal:  J Endocrinol Invest       Date:  1988-10       Impact factor: 4.256
View more
  1 in total

1.  Dehydroepiandrosterone sulphate plasma levels in normal women and patients with benign breast disease.

Authors:  E Parlati; I Liberale; P Morelli; P Serva; A Travaglini; A Piccione; E Menini; S Dell'Acqua
Journal:  J Endocrinol Invest       Date:  1992-02       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.